Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and development efforts and advance its next-generation AI drug design engine.
As a result, Isomorphic Labs said, it expects to expand its staff, adding top-tier talent as part of its next phase of growth.
“This funding will further…
Article Source
https://www.genengnews.com/topics/artificial-intelligence/deepmind-spinout-isomorphic-labs-raises-600m-toward-ai-drug-design/
